MEHA
Functional Brands, Inc. Common Stock
NASDAQ · Healthcare · Medical - Distribution · US
$0.00
−0.30%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 6.7M | 6.6M | 6.6M | 6.8M | 7.1M |
| Cost of Revenue | 3.0M | 3.1M | 3.0M | 3.6M | 4.0M |
| Gross Profit | 3.7M | 3.5M | 3.6M | 3.2M | 3.0M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 6.9M | 4.9M | 3.8M | 4.3M | 4.3M |
| General & Admin Expense | 6.1M | 4.3M | 3.3M | 3.7M | 3.5M |
| Selling & Marketing Expense | 892.8K | 632.4K | 576.3K | 588.8K | 796.9K |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 6.9M | 4.9M | 3.8M | 4.3M | 4.3M |
| Cost and Expenses | 9.9M | 8.0M | 6.8M | 7.9M | 8.4M |
| Operating Income (EBIT) | (3.2M) | (1.4M) | (229.1K) | (1.1M) | (1.3M) |
| Non-Operating | |||||
| Interest Income | 81.2K | 74.7K | 1.6K | — | — |
| Interest Expense | 359.9K | 402.4K | 331.8K | 158.6K | 133.1K |
| Net Interest Income | (278.7K) | (327.7K) | (330.3K) | (158.6K) | (133.1K) |
| Other Non-Op Income/Expense | (5.3M) | 2.2M | (330.3K) | (158.6K) | 395.5K |
| Non-Operating Income (excl Interest) | — | — | (1.6K) | — | (528.6K) |
| EBT (Pre-Tax Income) | (8.5M) | 758.5K | (559.4K) | (1.2M) | (942.3K) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (8.5M) | 758.5K | (559.4K) | (1.2M) | (942.3K) |
| Earnings from Cont. Ops | (8.5M) | 758.5K | (559.4K) | (1.2M) | (942.3K) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (8.5M) | 758.5K | (559.4K) | (1.2M) | (942.3K) |
| Per Share | |||||
| Basic EPS | ($0.78) | $0.08 | ($0.08) | ($0.15) | ($0.11) |
| Diluted EPS | ($0.09) | $0.01 | ($0.08) | ($0.15) | ($0.11) |
| Revenue Per Share | $0.16 | $0.80 | $0.98 | $0.80 | $0.83 |
| Shares | |||||
| Basic Shares Outstanding | 42.7M | 8.2M | 6.7M | 8.5M | 8.5M |
| Diluted Shares Outstanding | 42.7M | 85.1M | 6.7M | 8.5M | 8.5M |
| Profitability Metrics | |||||
| EBITDA | (2.5M) | (1.0M) | 173.9K | (648.0K) | (250.8K) |
| D&A | 738.4K | 353.1K | 401.4K | 434.5K | 558.5K |
| EBIT | (3.2M) | (1.4M) | (227.5K) | (1.1M) | (809.3K) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026